Retrospective observational study to evaluate the use of siponimod (MAyzent) in patients with Secondary Progressive Multiple Sclerosis in routine clinical practice in Spain. RESYZE Study
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: NOVARTIS FARMACEUTICA, SA
- Execution start: 12/09/2022
- End of execution: 30/09/2023
- PI: FRANCISCO JAVIER BARRERO HERNANDEZ
